118 related articles for article (PubMed ID: 2296230)
1. Pharmaceutical promotion.
Harvey K
Med J Aust; 1990 Jan; 152(2):57-8. PubMed ID: 2296230
[No Abstract] [Full Text] [Related]
2. Drug advertising.
Med J Aust; 1987 Jun; 146(12):660-1. PubMed ID: 3626920
[No Abstract] [Full Text] [Related]
3. Drug advertising.
Moulds RF; Wing LM
Med J Aust; 1989 Apr; 150(7):410-1. PubMed ID: 2716670
[No Abstract] [Full Text] [Related]
4. Pharmaceutical advertising: from prospectus to marketing.
Cambronero-Saiz B
J Epidemiol Community Health; 2007 Apr; 61(4):366. PubMed ID: 17372300
[No Abstract] [Full Text] [Related]
5. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
Hayes TA
Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
[No Abstract] [Full Text] [Related]
6. Enforcement of codes governing pharmaceutical promotion: what happens when companies breach advertising guidelines?
Lexchin J
CMAJ; 1997 Feb; 156(3):351-6. PubMed ID: 9033415
[TBL] [Abstract][Full Text] [Related]
7. [Pharmaceutic promotion and publicity: quo vadis?].
Castillo Pérez P
Med Clin (Barc); 1992 Sep; 99(8):305-9. PubMed ID: 1453825
[No Abstract] [Full Text] [Related]
8. Advertising standards.
Drug Ther Bull; 2013 Jul; 51(7):73. PubMed ID: 23842632
[No Abstract] [Full Text] [Related]
9. [On ethical issues of pharmaceutical communication. National Association of Hungarian Pharmaceutical Manufacturers and Wholesalers].
Kata M; Sánta Z
Orv Hetil; 1994 Oct; 135(42):2343-7. PubMed ID: 7970650
[No Abstract] [Full Text] [Related]
10. Letter: Assessment of advertising.
Wigle WW
Can Med Assoc J; 1974 Apr; 110(7):759. PubMed ID: 4825144
[No Abstract] [Full Text] [Related]
11. Drug advertisements in Indian medical journals.
Lal A; Sharma ML
Indian J Physiol Pharmacol; 1992 Apr; 36(2):139-40. PubMed ID: 1506082
[No Abstract] [Full Text] [Related]
12. Ethical code of the pharmaceutical industry in Slovakia. (Excerpts).
Med Etika Bioet; 2004; 11(3-4):11-22. PubMed ID: 16294449
[No Abstract] [Full Text] [Related]
13. Monitoring pharmaceutical company promotions.
Gillette RD
Fam Med; 1991 Feb; 23(2):92. PubMed ID: 2037220
[No Abstract] [Full Text] [Related]
14. Regulating pharmaceutical advertising: what will work?
Shapiro MF
CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
[TBL] [Abstract][Full Text] [Related]
15. Sin of omission? Pharmaceutical trade group failed to disclose that ad subject was employee.
Becker C
Mod Healthc; 2001 Aug; 31(32):5, 8. PubMed ID: 11507868
[No Abstract] [Full Text] [Related]
16. Drug advertising.
Bell KD
Med J Aust; 1987 Oct; 147(7):361. PubMed ID: 3657662
[No Abstract] [Full Text] [Related]
17. Can drug companies have it both ways?
Rapp MS
CMAJ; 1997 Apr; 156(7):982-3. PubMed ID: 9099165
[No Abstract] [Full Text] [Related]
18. Standards for pharmaceutical advertising in Canada.
Chepesiuk R
CMAJ; 2005 Aug; 173(3):238; author reply 238. PubMed ID: 16076811
[No Abstract] [Full Text] [Related]
19. Pharmaceutical advertising in ophthalmology.
Kahawita SK; Casson RJ
Clin Exp Ophthalmol; 2012 Mar; 40(2):216-7. PubMed ID: 21902791
[No Abstract] [Full Text] [Related]
20. The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada.
Desjardins JG
CMAJ; 1997 Feb; 156(3):363-4. PubMed ID: 9033417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
